Alan Franklin, M.D., Ph.D.

Alan Franklin, MD, PhD, a board-certified ophthalmologist, brings a distinguished academic and professional background to Retina Specialty Institute as the co-founder and chief medical officer of RFE Pharma Company.

Dr. Franklin’s educational experience began at Northwestern University, where he earned a Bachelor of Science degree in biomedical engineering and lettered in Varsity Track. He then attended the Medical College of Ohio where he received his Doctor of Medicine degree.

Having a longstanding interest in diabetes, Dr. Franklin went on to earn a PhD degree in diabetes-related research at Vanderbilt University. He completed his first year in internal medicine at Vanderbilt while writing and defending his PhD thesis.

He pursued the specialty of ophthalmology based his longstanding interests in taking care of diabetics and studies of diabetic eye disease, and fulfilled his residency at St. Louis University School of Medicine.

He then completed a two-year fellowship in vitreoretinal disease and surgery at University of Iowa Medical Center, where he was awarded the prestigious Heed-Knapp fellowship both years of his fellowship. His work on potential new treatments for diabetic retinopathy and macular degeneration was awarded best research project by a physician in training for the United States during his last year of fellowship.

Dr. Franklin is the guiding force behind RFE Pharma, a research entity dedicated to the development of new treatments for such retinal diseases as macular degeneration and diabetic retinopathy. Through this research, Dr. Franklin has been instrumental in developing several patented drug formulations, and a patented drug delivery device.

He is widely published in the fields of retinal cell biology and retinal genetics. He acts as an advisor for ultra-small gauge vitrectomy surgery and retinal surgical imaging.

He also serves on the advisory committees and speakers’ boards of leading corporations in the pharmaceutical industry, including Novartis, Alcon, and QLT. He is the editor for Modern Retina, a journal directed at physician education.

Dr. Franklin has lived in Mobile since 2005 with his wife Susan and their four children: Isabel, Max, Sam and Cal. His family stays busy with community, school, and sports activities.

Dr. Franklin is devoted to the prevention and treatment of retinal diseases by bringing the best and newest technology to the region. He joined Retina Specialty Institute (RSI) in 2005. RSI, a multi-physician group practice, is one of the largest and most-respected retina research organizations in the nation, with offices in Alabama, Florida, Louisiana and Mississippi. Besides offering state-of-the art clinical and surgical skills to patients, RSI is nationally recognized for its clinical trials, research and innovative product development, and breakthrough disease prevention protocols.